Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.
AUTOR(ES)
Hunt, L M
RESUMO
BACKGROUND: People with a family history of colorectal cancer have an increased risk of the disease themselves. Many centres are advocating family history screening by endoscopy. AIMS: The performance of chemical and immunological faecal occult blood tests (Haemoccult and Hemeselect) in 212 subjects with a family history of colorectal cancer was assessed. RESULTS: Both Hemeselect and Haemoccult were positive in the only patient with colorectal cancer. Hemeselect was more sensitive than Haemoccult for adenomas (40% compared with 20%) (adenomas larger than 1 cm 75% compared with 50%). No additional abnormality was detected by the addition of Haemoccult or Hemeselect to 60 cm flexible sigmoidoscopy in screening people at lower levels of familial risk. A false positive rate of 16% for Hemeselect resulted in a high proportion of additional colonoscopies in this group. CONCLUSIONS: At present faecal occult blood tests are not sufficiently sensitive or specific to replace endoscopy in screening people at risk of familial colorectal cancer.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1027018Documentos Relacionados
- Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in England.
- Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer.
- Controlled prospective study of faecal occult blood screening for colorectal cancer in Bury, black pudding capital of the world
- A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult
- Screening for colorectal cancer.
